FSD Pharma Inc.

NASDAQ
HUGE
Stock
Yield per half year: 0%
Dividend yield: 0%
Sector: Healthcare

Share chart FSD Pharma Inc.

About FSD Pharma Inc.

FSD Pharma Inc., a biotechnology company, operates in the pharmaceutical research and development business. Its lead candidate is FSD-201, an ultra-micronized palmitoylethanolamide for the treatment of inflammatory diseases. The company is also involved in the research and development of Lucid-Psych, a molecular compound identified for the treatment of mental health disorders; and Lucid-MS, a molecular compound identified for the treatment of neurodegenerative disorders. FSD Pharma Inc. was incorporated in 1998 and is headquartered in Toronto, Canada.

Main settings

IPO date 2018-06-08
ISIN CA35954B2066
Industry IT Services
Sector Information Technology
Валюта usd
Валюта отчета usd
Сайт link
Цена ао 5.39
Change price per day: 0% (5.39)
Change price per week: 0% (5.39)
Change price per month: 0% (5.39)
Change price per 3 month: 0% (5.39)
Change price per half year: 0% (5.39)
Change price per year: +1 462.32% (0.345)
Change price per 3 year: +512.5% (0.88)
Change price per 5 year: +65.41% (3.2586)
Change price per year to date: 0% (5.39)

Grade

Underestimation
Title Value Grade
P/S 0 0
P/BV 189.74 1
P/E 0 0
EV/EBITDA -140.1 0
Total: 0.375
Efficiency
Title Value Grade
ROA, % -106.78 0
ROE, % -140.97 0
Total: 0
Dividends
Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0
Debt
Title Value Grade
Debt/EBITDA -0.0194 10
Total: 10
Growth impulse
Title Value Grade
Yield Revenue, % -98.84 0
Yield Ebitda, % -31.32 0
Yield EPS, % -91.74 0
Total: 0

Main owners

Similar companies



Company management

Head Job title Payment Year of birth
Mr. Zeeshan Saeed Founder, CEO, President & Executive Co-Chairman 222.62k 1970 (55 years)
Mr. Anthony John Durkacz Founder & Executive Co-Chairman 222.62k 1976 (49 years)
Mr. Nathan Coyle CPA Chief Financial Officer 178.21k 1981 (44 years)
Mr. Donal Carroll CPA Chief Operating Officer 225.62k 1977 (48 years)
Dr. Lakshmi P. Kotra BPHARM, Ph.D. CEO of Lucid & Director 144.72k 1971 (54 years)
Dr. Andrzej Chruscinski M.D., Ph.D. Vice President of Clinical & Scientific Affairs of Lucid 110.3k
Mr. Kevin Cassidy Vice President of Quality-Lucid 144.82k
Ms. Maryann Adesso Corporate Secretary N/A
Randell Mack President of FSD BioSciences N/A

About company

Address: Canada, Toronto. ON ML A, 199 Bay Street - Open in google maps, Open in yandex maps
Website: https://www.fsdpharma.com